Upon infection of PFA-treated cells with wild type meningococci, some TMS containing endogenous CD9 still developed at the interface with bacteria (Fig. 4A), although much less numerous (Fig. 4D, E) and shorter (Fig. 4C, E) than in living cells. This evidence concerns the gene CD9 and infection.